
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
Description
About HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
The Hepatitis B Virus (HBV) genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein Peptide (IEDB: 61745) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Capsid protein Peptide, H-STLPETTVVRR-OH (Uniprot: P03149 aa: 141-151) from JPT is produced under strict quality control and quality management.
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR - Specifications
- Peptide sequence: H-STLPETTVVRR-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Hepatitis
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
References:
Read References with JPT’s Antigen Peptides
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR has been described in:
HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis., J Exp Med, 1993 (PMID: 7679709)
Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes., J Immunol, 1997 (PMID: 9366399)
Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells., J Immunother, 2011 (PMID: 21904219)
Documentation
Documentation for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
Properties
Properties of HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Hepatitis |
Layout: | Freeze-dried in glass vial |
Organism: | Hepatitis B Virus (HBV) |
Protein Name: | Capsid protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 141-151, STLPETTVVRR
Information | Values |
---|---|
Sequence: | H-STLPETTVVRR-OH |
Specifications: | 11mer peptide as TFA salt |